Levels of extra domain A containing fibronectin in human atherosclerotic plaques are associated with a stable plaque phenotype

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages

  van Keulen, J Karlijn ^a,b   de Kleijn, Dominique P ^a,b   Nijhuis, Manon M Oude ^a,b   Busser, Els ^a   Velema, Evelyn ^a   Fijnheer, Rob ^a   van der Graaf, Yolanda ^a   Moll, Frans L ^a   de Vries, Jean Paul ^c   Pasterkamp, Gerard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Atherosclerosis; Extra domain A; Fibronectin; Plaque

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; EXTRA DOMAIN A; FIBRONECTIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID STORAGE; MAJOR CLINICAL STUDY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE;

ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COHORT STUDIES; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASES; PHENOTYPE; PROSPECTIVE STUDIES; PROTEIN STRUCTURE, TERTIARY; RISK FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 35248828544     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.03.014     Document Type: Article

References (32)

1. Hynes R.O. Fibronectins. Fibronectins (1990), Springer-Verlag, New York
2. Brown L.F., Dubin D., Lavigne L., et al. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 142 March (1993) 793-801
3. Ffrench-Constant C., Van De W.L., Dvorak H.F., and Hynes R.O. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109 August (1989) 903-914
4. Van Der Straaten H.M., Canninga-van Dijk M., Verdonck L.F., et al. Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease. J Invest Dermatol 123 December (2004) 1057-1062
5. Barnes J.L., Hastings R.R., and De la Garza M.A. Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145 September (1994) 585-597
6. Jarnagin W.R., Rockey D.C., Koteliansky V.E., Wang S.S., and Bissell D.M. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127 December (1994) 2037-2048
7. Kuhn C., Boldt J., King T.E.J., et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140 December (1989) 1693-1703
8. Kanters S.D., Banga J.D., Algra A., et al. Plasma levels of cellular fibronectin in diabetes. Diabetes Care 24 February (2001) 323-327
9. Peters J.H., Carsons S., Kalunian K., et al. Preferential recognition of a fragment species of osteoarthritic synovial fluid fibronectin by antibodies to the alternatively spliced EIIIA segment. Arthritis Rheum 44 November (2001) 2572-2585
10. Coito A.J., Brown L.F., Peters J.H., Kupiec-Weglinski J.W., and Van De Water L. Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts. Am J Pathol 150 May (1997) 1757-1772
11. Dubin D., Peters J.H., Brown L.F., et al. Balloon catheterization induced arterial expression of embryonic fibronectins. Arterioscler Thromb Vasc Biol 15 November (1995) 1958-1967
12. Glukhova M.A., Frid M.G., Shekhonin B.V., et al. Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol 109 July (1989) 357-366
13. Takasaki I., Chobanian A.V., Mamuya W.S., and Brecher P. Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension 20 July (1992) 20-25
14. Okamura Y., Watari M., Jerud E.S., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276 March (2001) 10229-10233
15. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 December (1998) 2085-2088
16. Ohashi K., Burkart V., Flohe S., and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164 January (2000) 558-561
17. Xu X.H., Shah P.K., Faure E., et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104 December (2001) 3103-3108
18. Hollestelle S.C., De Vries M.R., Van Keulen J.K., et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109 January (2004) 393-398
19. Michelsen K.S., Wong M.H., Shah P.K., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101 July (29) (2004) 10679-10684
20. Pasterkamp G., Galis Z.S., and De Kleijn D.P. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 24 April (4) (2004) 650-657
21. Vink A., Schoneveld A.H., Van Der Meer J.J., et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106 October (2002) 1985-1990
22. Wright S.D., Burton C., Hernandez M., et al. Infectious agents are not necessary for murine atherogenesis. J Exp Med April (2000) 1437-1442
23. Tan M.H., Sun Z., Opitz S.L., et al. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 1 July (104) (2004) 11-18
24. Verhoeven B.A., Velema E., Schoneveld A.H., et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol 19 (2004) 1127-1133
25. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., and Van Der G.Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 15 October (1999) 773-781
26. Peters J.H., Maunder R.J., Woolf A.D., Cochrane C.G., and Ginsberg M.H. Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med 113 May (5) (1989) 586-597
27. Sluijter J.P., Pulskens W.P., Schoneveld A.H., et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 37 January (1) (2006) 235-239
28. Verhoeven B., Hellings W.E., Moll F.L., et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg 42 December (6) (2005) 1075-1081
29. Singh P., Reimer C.L., Peters J.H., et al. The spatial and temporal expression patterns of integrin alpha9beta1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J Invest Dermatol 123 December (2004) 1176-1181
30. Sasu S., LaVerda D., Qureshi N., Golenbock D.T., and Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 89 August (2001) 244-250
31. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 March (2002) 1158-1161
32. Strauss B.H., Chisholm R.J., Keeley F.W., et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 75 October (4) (1994) 650-658